Accovion establishes new subsidiary in the UK

As a European full-service Clinical Research Organization, Accovion supports local and global projects of all types and phases for the Pharmaceutical, Biotechnology and Medical Device industries. Its services include project planning and management, clinical trial execution, clinical monitoring, data management, adverse event management including post-marketing surveillance, biostatistics and statistical programming, medical writing and electronic publishing.

The new subsidiary in the UK tangibly underscores Accovion's growth target. Ivana Waller, Accovion's Chief Operating Officer stated: "The UK has always represented a key strategic territory for Accovion. In addition, with our increasing regulatory portfolio, our growing involvement in device pharmacovigilance and health economics, it had become imperative for us to be firmly implanted in London. Our new subsidiary consolidates our presence in Europe and affords us a sure platform to access the considerable local clinical research talent and respond even better to our clients' growing needs. We are very pleased to bring on board an experienced Managing Director - Mr. Carl Naraynassamy - who is well respected for his contributions to the fields of clinical research and pharmaceutical medicine education globally. I am confident that with his vision, business acumen and clinical research expertise, Accovion's operations in the UK will continue to prosper."

In 2011, Accovion's strategic plan includes formalizing activities in several other European countries by establishing additional subsidiaries. With its active, well-planned expansion, Accovion aims to offer its clients a broader spectrum of country-specific clinical research expertise, all under one roof and all providing the quality services that Accovion is known for.